Abstract: A graphene biosensor is formed on an electrically insulating substrate with a single-layer graphene sheet arranged between two metallic electrodes. The graphene sheet is in electrical contact with the metallic electrodes. The graphene sheet has perforations creating edges in the graphene sheet. The perforations may be holes on a micrometer scale or in a nanometer scale. The biosensor can be configured as an ISFET. The graphene sheet may comprise affinity probes immobilized on the edges for attaching specific molecules to the graphene sheet. Several graphene sheets may be arranged in a microarray with different affinity probes on different graphene sheets. The sensor may also be arranged on the distal end of a catheter for in situ measurements in a body vessel.
Abstract: The present disclosure describes genetically-modified plants having enhanced tolerance to multiple abiotic stressors, such as extreme temperatures (heat or cold) and/or drought. Abiotic stress tolerance is enhanced by ectopic expression of a heterologous glutaredoxin. Abiotic stress tolerance (particularly drought) is also enhanced by inhibited function, activity, or expression of an endogenous glutaredoxin. Methods of producing such genetically-modified plants are also disclosed.
Type:
Application
Filed:
August 31, 2012
Publication date:
February 5, 2015
Applicants:
BAYLOR COLLEGE OF MEDICINE, KANSAS STATE UNIVERSITY RESEARCH FOUNDATION
Inventors:
Sunghun Park, Frank White, Jungeun Park, Kendal Hirschi, Ning-Hui Cheng
Abstract: The present invention provides small molecules useful to affect cancer cells, along with related methods. The present compounds, formulations, kits and methods are useful for a variety of research, diagnostic and therapeutic purposes. STAT3 inhibitors, particularly LLL12, are disclosed. The STAT3 inhibitors are useful to treat breast cancer in general and breast cancer initiating cells in particular.
Type:
Application
Filed:
October 16, 2014
Publication date:
February 5, 2015
Applicants:
NATIONWIDE CHILDREN'S HOSPITAL, INC., THE OHIO STATE UNIVERSITY
Abstract: A method is provided in which pretreated and densified cellulosic biomass particulates can be hydrolyzed at a high solids loading rate as compared with the solids loading rate of loose hydrolysable cellulosic biomass fibers. The resulting high concentration sugar-containing stream can be easily converted to biofuels or an entire suite of other useful bioproducts.
Type:
Grant
Filed:
April 27, 2012
Date of Patent:
February 3, 2015
Assignees:
The Michigan Biotechnology Institute, Board of Trustees of Michigan State University
Inventors:
Bryan Bals, Farzaneh Teymouri, Tim Campbell, Bruce Dale
Abstract: An exemplary method includes selecting at least one light source configured to generate light at a particular wavelength and applying the light to tissue following an ischemic event. Applying the light to the tissue inhibits cytochrome c oxidase activity. Another exemplary method includes selecting at least one light source configured to generate light at a particular wavelength and applying the light to tissue following an ischemic event and prior to either reoxygenation of the tissue or clinical intervention to reduce cell damage. An exemplary light therapy device includes at least one light source configured to generate light having a wavelength of at least one of approximately 730-770 nm, 850-890 nm, 880-920 nm, and 930-970 nm.
Type:
Grant
Filed:
April 30, 2010
Date of Patent:
February 3, 2015
Assignee:
Wayne State University
Inventors:
Maik Huttemann, Icksoo Lee, John Kamholz, Lawrence Grossman, Karin Przyklenk, Thomas Sanderson
Abstract: Platinum complexes that exhibit photoabsorption and photoemission, methods of making such complexes, and applications thereof are disclosed, including optical devices comprising the complexes.
Type:
Grant
Filed:
April 6, 2010
Date of Patent:
February 3, 2015
Assignee:
Arizona Board Of Regents Acting For And On Behalf Of Arizona State University
Abstract: A nanoshell is disclosed, comprising a star polymer occlusion complex comprising i) an amphiphilic unimolecular star polymer having a crosslinked core covalently linked to 6 or more independent polymer arms, and ii) a cargo material occluded in the star polymer; and a shell comprising an inorganic material in contact with a peripheral surface of the star polymer occlusion complex.
Type:
Grant
Filed:
March 18, 2011
Date of Patent:
February 3, 2015
Assignees:
International Business Machines Corporation, San Jose State University Research Foundation
Inventors:
Victor Yee-Way Lee, Robert Dennis Miller, Joseph Sly, Melia Tjio
Abstract: An interspinous spacer device for the treatment of high-grade spinal disorders is disclosed herein. The interspinous spacer device includes a sliding rod and a base that contains a curved internal track that limits the range of motion and center of rotation of the spinal segments stabilized using the device to the physiological levels of a nondegraded spinal segment.
Type:
Grant
Filed:
September 2, 2011
Date of Patent:
February 3, 2015
Assignee:
Colorado State University Research Foundation
Inventors:
Christian M. Puttlitz, Benjamin C. Gadomski
Abstract: Disclosed are extracts prepared from primitive plants and fungi that have anti-cancer properties. The extracts are prepared by pulverizing the biological matter in a diluent. The extract can be administered to an individual or animal to kill cancer cells, prevent growth of cancer cells and teat cancer. The extracts may be used in combination with other therapeutic protocols.
Abstract: In a method of moving droplets, local heat is applied to a surface portion of a droplet for an amount of time sufficient to create a Marangoni flow in the droplet. Droplets are suspended in an emulsion in a carrier liquid on a substrate. A laser beam is used to move one of the droplets. the droplet consists of a first substance and a carrier liquid consists of a second substance that is not mixable with the first substance. The droplet is placed in the carrier liquid, and the mixture is emulsified. The emulsified mixture is placed on a substrate. Then the local heat is applied to the surface of the droplet. The first substance may include oil and the second substance may include water.
Abstract: An opto-mechanical deployable telescope includes a hub, at least one deployable multiple petal primary mirror mounted to the hub, a deployment assembly, and a deployment engine assembly. The deployment assembly is operable to move the at least one primary mirror between a stowed position and a deployed position. The deployment engine assembly is operable to power the deployment assembly using stored mechanical energy. The deployment assembly includes a kinematic or semi-kinematic interface between the hub and the at least one primary mirror to hold petals of the at least one primary mirror in alignment relative to each other in the deployed position.
Type:
Grant
Filed:
February 27, 2012
Date of Patent:
February 3, 2015
Assignee:
Utah State University Research Foundation
Inventors:
Trent Newswander, Blake Crowther, James Champagne, Adam Norris
Abstract: In general, in one aspect, the invention features a method that includes using an optical coherence tomography system to acquire a plurality of frames of a sample where each frame includes optical information about the composition of the sample through a section of the sample. The method further includes averaging over two or more of the frames to provide an image of the section of the sample where successive frames of the two or more frames are acquired with a time lapse of 0.05-0.7 seconds. Embodiments of the method may have unique advantages for endoscopic subcellular imaging. For example, they can enable subcellular imaging with low-NA optics (e.g., NA=0.25 or less) while providing morphological imaging of the underlying tissue up to 0.6 mm without focal tracking.
Type:
Grant
Filed:
September 18, 2008
Date of Patent:
February 3, 2015
Assignee:
The Research Foundation of State University of New York
Abstract: Fault Current Limiters (FCL) provide protection for upstream and/or downstream devices in electric power grids. Conventional FCL require the use of expensive conductors and liquid or gas cryogen handling. Disclosed embodiments describe FCL systems and devices that use lower cost superconductors, require no liquid cryogen, and are fast cycling. These improved FCL can sustain many sequential faults and require less time to clear faults while avoiding the use of liquid cryogen. Disclosed embodiments describe a FCL with a superconductor and cladding cooled to cryogenic temperatures; these are connected in parallel with a second resistor across two nodes in a circuit. According to disclosed embodiments, the resistance of the superconducting components and its sheath in the fault mode are sufficiently high to minimize energy deposition within the cryogenic system, minimizing recovery time.
Type:
Grant
Filed:
July 29, 2011
Date of Patent:
February 3, 2015
Assignee:
The Ohio State University
Inventors:
Michael Sumption, Edward Collings, Milan Majoros
Abstract: Excimers are formed in a high pressure gas by applying a potential between a first electrode (14, 214) and a counter electrode (25, 226) so as to impose an electric field within the gas, or by introducing high energy electrons into the gas using an electron beam. A phosphor for converting the wavelength of radiation emitted from the formed excimers is disposed within the gas and outside a region (62, 162) where the excimers are expected to be formed, so as to avoid degradation of the phosphor.
Type:
Grant
Filed:
May 15, 2009
Date of Patent:
February 3, 2015
Assignee:
Rutgers, The State University
Inventors:
Daniel E. Murnick, Nazieh Mohammad Masoud, Richard Riman
Abstract: The present invention provides methods for tumor treatment by administering an inhibitor of quiescin sulfhydryl oxidase 1 (QSOX1), compositions comprising such inhibitors, and methods for identifying such inhibitors.
Type:
Grant
Filed:
March 20, 2013
Date of Patent:
February 3, 2015
Assignee:
Arizona Board of Regents, a Body Corporate of the State of Arizona Acting for and on Behalf of Arizona State University
Abstract: Some embodiments include an apparatus for testing flexible displays. The apparatus can include: (a) a first clamp configured to receive a first end of the flexible display; (b) a second clamp configured to receive a second end of the flexible display, wherein the second end of the flexible display is opposite the first end of the flexible display; and (c) a test column. Other embodiments and methods are disclosed herein.
Type:
Grant
Filed:
November 28, 2011
Date of Patent:
February 3, 2015
Assignee:
Arizona Board of Regents, a body corporate of the State Arizona, Acting for and on behalf of Arizona State University
Inventors:
Cynthia Bell, Terry L. Alford, Roy Stephen Rednour, Mark Richards
Abstract: The present invention discloses the discovery that miR-21 targets and down-regulates the core mismatch repair (MMR) recognition protein complex hMSH2 and hMSH6. Anti-sense miR-21 is therefore proven as therapeutic herein. Therefore, compositions, kits, therapies and other methods, including methods of treatment/amelioration of symptoms, are disclosed in the present invention.
Abstract: Hybrids and derived cultivars of the rice cultivar designated ‘CL151’ are disclosed. The invention relates to hybrid rice seeds and plants produced by crossing the cultivar ‘CL151’ with another rice cultivar. The invention further relates to other derivatives of the rice cultivar ‘CL151.
Type:
Grant
Filed:
November 18, 2009
Date of Patent:
February 3, 2015
Assignee:
Board of Supervisors of Louisiana State University And Agricultural and Mechanical College
Abstract: A method for repairing an injury of cartilage in a patient by local administration of an organovanadium agent or use of an implantable device for delivery of an organovanadium agent. Implantable devices containing an organovanadium agent and methods of making these implantable devices are also disclosed.
Type:
Application
Filed:
July 6, 2012
Publication date:
January 29, 2015
Applicant:
RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
Inventors:
Sheldon S. Lin, David N. Paglia, James P. O'Connor, Aaron Wey, Joseph Benevenia, Virak Tan